These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8825684)

  • 21. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
    Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
    Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA adduct formation in mice treated with ochratoxin A.
    Pfohl-Leszkowicz A; Chakor K; Creppy EE; Dirheimer G
    IARC Sci Publ; 1991; (115):245-53. PubMed ID: 1820338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The involvement of mycotoxins in the development of endemic nephropathy.
    Peraica M; Domijan AM; Miletić-Medved M; Fuchs R
    Wien Klin Wochenschr; 2008; 120(13-14):402-7. PubMed ID: 18726664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of p53 knockout on ochratoxin A-induced genotoxicity in p53-deficient gpt delta mice.
    Hibi D; Kijima A; Suzuki Y; Ishii Y; Jin M; Sugita-Konishi Y; Yanai T; Nishikawa A; Umemura T
    Toxicology; 2013 Feb; 304():92-9. PubMed ID: 23261758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ochratoxin A genotoxicity, relation to renal tumors].
    Maaroufi K; Pfohl-Leszkowicz A; Achour A; el May M; Grosse Y; Hammami M; Ellouz F; Creppy EE; Bacha H
    Arch Inst Pasteur Tunis; 1994; 71(1-2):21-31. PubMed ID: 7661650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity.
    Mosesso P; Cinelli S; Piñero J; Bellacima R; Pepe G
    Chem Res Toxicol; 2008 Jun; 21(6):1235-43. PubMed ID: 18500787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of nephrotoxicity of ochratoxin A, a food contaminant.
    Creppy EE; Baudrimont I; Betbeder AM
    Toxicol Lett; 1995 Dec; 82-83():869-77. PubMed ID: 8597155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment and characterisation of yeast-based products intended to mitigate ochratoxin exposure using in vitro and in vivo models.
    Pfohl-Leszkowicz A; Hadjeba-Medjdoub K; Ballet N; Schrickx J; Fink-Gremmels J
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(4):604-16. PubMed ID: 25296248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ochratoxin A: the continuing enigma.
    O'Brien E; Dietrich DR
    Crit Rev Toxicol; 2005 Jan; 35(1):33-60. PubMed ID: 15742902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-activity relationships for covalent DNA adduction.
    Tozlovanu M; Faucet-Marquis V; Pfohl-Leszkowicz A; Manderville RA
    Chem Res Toxicol; 2006 Sep; 19(9):1241-7. PubMed ID: 16978030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathy.
    Nikolov IG; Petkova-Bocharova D; Castegnaro M; Pfohl-Leskowicz A; Gill C; Day N; Chernozemsky IN
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):201-7. PubMed ID: 9216807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
    Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ
    Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents.
    Mally A; Dekant W
    Mol Nutr Food Res; 2009 Apr; 53(4):467-78. PubMed ID: 19072886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA adduct formation by ochratoxin A: review of the available evidence.
    Mally A; Dekant W
    Food Addit Contam; 2005; 22 Suppl 1():65-74. PubMed ID: 16332624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ochratoxin A: lack of formation of covalent DNA adducts.
    Mally A; Zepnik H; Wanek P; Eder E; Dingley K; Ihmels H; Völkel W; Dekant W
    Chem Res Toxicol; 2004 Feb; 17(2):234-42. PubMed ID: 14967011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha.
    Föllmann W; Hillebrand IE; Creppy EE; Bolt HM
    Arch Toxicol; 1995; 69(4):280-6. PubMed ID: 7755490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structures of covalent adducts between DNA and ochratoxin a: a new factor in debate about genotoxicity and human risk assessment.
    Mantle PG; Faucet-Marquis V; Manderville RA; Squillaci B; Pfohl-Leszkowicz A
    Chem Res Toxicol; 2010 Jan; 23(1):89-98. PubMed ID: 19928877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of ochratoxin A biomarkers in biological materials obtained from patients suffering from renal cell carcinoma.
    Malir F; Louda M; Toman J; Ostry V; Pickova D; Pacovsky J; Brodak M; Pfohl-Leszkowicz A
    Food Chem Toxicol; 2021 Dec; 158():112669. PubMed ID: 34774926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures.
    Degen GH; Gerber MM; Obrecht-Pflumio S; Dirheimer G
    Arch Toxicol; 1997; 71(6):365-71. PubMed ID: 9195018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.